Sisram Medical’s associate company Tianjin JuveStar released Phase IIb result of lipolysis injection, reduction of submental fat by 15% through one treatment
LMNT, Sisram Medical’s Home-use Brand, is Officially Launching in China
Alma, a Sisram Medical Company, Announces the Launch of Alma TED™ and the Company’s Professional Skincare Line for the U.S. Market
Sisram Medical Ltd Announces 2021 Record Annual Results. Strong Performance Led by Synergistic Development of Four Main Business Lines Under One Ecosystem.
Sisram Medical has Increased the Shares by the Controlling Shareholder Fosun Pharma, Demonstrating Shareholder’s Strong Confidence
Alma Hybrid Platform by Alma, a Sisram Medical company, Wins 2021 Gold Award for Industrial and Life Science Medical/Scientific Machinery Design
Sisram Medical Ltd, Announces Its Interim Results for the First Half of 2021 Demonstrating an Impressive Performance Led by Global Business Expansion and R&D Breakthroughs
Sisram Medical (1696.HK) and Fosun Industrial Enter into a Sublicense Agreement for the Commercialization of DaxibotulinumtoxinA (RT002) Injectable
Sisram Medical Group expects to record significant increases of more than 73% in its revenue and more than 190% in its profits for the First 6 Months of 2021, as compared to that for the corresponding period in 2020.
Sisram Medical Expands its Dental Business Line with Proposed Acquisition of Shanghai Foshion Medical System, a Leading Dental Equipment Sales & Marketing Platform in China